Treatment effect and safety of seltorexant as monotherapy for patients with major depressive disorder: a randomized, placebo-controlled clinical trial.

In both that study and the current study the treatment effect for 20 mg seltorexant had a moderate effect size and was statistically significant, while the corresponding improvement on the 40 mg dose of seltorexant did not reach statistical significance.

also in 111,027 other papers